ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.
Janet Lambert, CEO, ARM
The presentation provides a preview of the trends and metrics that will be examined in ARM’s upcoming H1 2020 report.
Download Presentation
Janet Lambert, CEO, ARM
The presentation, which provides an overview on value demonstration for cell and gene therapies, cites information from ARM’s library of original policy analyses.
Download PresentationPotentially curative cell and gene therapies are changing the face of medicine and providing hope to patients where there was once none. But how will they be paid for? This webinar discusses the implementation of value-based payment models for innovative therapies.
The webinar includes discussion around how COVID-19 changes the way we think about healthcare decision making and places intense pressure on financial management at all levels of the health system.
Watch RecordingThis webinar highlights potential treatments for Acute Respiratory Distress syndrome (ARDS) in COVID-19 patients. Two therapeutic developers, Athersys and Pluristem Therapeutics, presented on their treatment approaches and plans for near term clinical trials.
Watch Recording
